Limiting dilution transplantation experiments were then performed to validate that the CD24+/ALDH1+/CD44high cells do in fact have greater tumor initiating ability than CD24+/ALDH1-/CD44low cells. The gene discussed is ALDH1A1; the disease is neoplasm.